Gene therapy trial markedly cuts bleeding risk in haemophilia B patients

Single injection of FLT180 removes need for people to inject weekly with clotting factors, study findsA new gene therapy has dramatically cut the risk of bleeding in people with the rare condition haemophilia B, experts have said.Researchersfound that a single injection of the gene therapy, called FLT180a, removed the need for people to inject themselves weekly with clotting factors.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Genetics Health Biology Science Research UK news Source Type: news